the patient celiac

It's not too late to enroll in the CeliAction Study

1 comments July 08, 2014

I recently learned that the CeliAction Study will be enrolling subjects with celiac disease through the end of July 2014. The ALV003 enzyme is being studied as a treatment to augment the gluten-free diet by providing protection from gluten cross-contamination. It is also being researched as a treatment for nonresponsive celiac disease.  All questions about this post will be answered by a CeliAction Study representative. Thank you for reading!  -Jess

celiaction july

Managing celiac disease may be more than just a gluten-free diet.

A clinical research study called the CeliAction Study is researching if an investigational drug – which would be taken as a supplement to an attempted gluten-free diet – improves any symptoms of celiac disease.

You may qualify for the CeliAction Study if you:

• Have been diagnosed with celiac disease by a healthcare professional

• Are attempting to be on a gluten-free diet

• Have experienced at least one moderate or severe symptom of celiac disease in the past month

If you participate in the CeliAction Study, you:

• Will be able to maintain your current diet restrictions

• Will be provided with study-related care at no cost

• Do not need medical insurance to take part

• May be compensated for time and travel

• Will help advance medical research for celiac disease

To learn more about this research study and see if you qualify, visit or call 1-855-3333-ACT.

There’s formula from The Wise Alternative that’s supposed to completely help in eradicating celiac. Unlike ALV003, it’s not an enzyme or probiotic but the ingredients seem beneficial. Have you heard of it? J.E. Block, MD PhD FACP of Tulsa talks about it

And… Here is what they say on their website.
7/26/2016 2:55:16 PM
Copyright Jessica Madden All rights reserved